| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0006 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0003 | 1 |